Nova Pharma Solutions Berhad announced audited consolidated earnings results for the year ended December 31, 2017. For the period, the company's revenue was MYR 7,133,106 against MYR 7,371,802 a year ago. Profit before tax was MYR 2,658,563 against MYR 2,826,107 a year ago. Profit and total comprehensive income for the year was MYR 2,649,056 or MYR 2.21 per basic and diluted share against MYR 2,818,884 or MYR 2.35 per basic and diluted share a year ago. Net cash generated from operating activities was MYR 1,993,180 against MYR 2,957,677 a year ago. Purchase of property, plant and equipment was MYR 23,257 against MYR 92,277 a year ago.